Chugai Pharmaceutical Co Ltd
TSE:4519

Watchlist Manager
Chugai Pharmaceutical Co Ltd Logo
Chugai Pharmaceutical Co Ltd
TSE:4519
Watchlist
Price: 6 270 JPY -1.77% Market Closed
Market Cap: 10.3T JPY
Have any thoughts about
Chugai Pharmaceutical Co Ltd?
Write Note

EV/EBITDA
Enterprise Value to EBITDA

16.7
Current
14
Median
13.3
Industry
Higher than median
Higher than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
16.7
=
Enterprise Value
9.6T JPY
/
EBITDA
571.9B JPY
All Countries
Close

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
17.2
2-Years Forward
EV/EBITDA
16.7
3-Years Forward
EV/EBITDA
15.7

See Also

Discover More